Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 96,203

Document Document Title
WO/2017/093451A1
The present invention relates to a method of producing a recombinant polypeptide in a filamentous fungus which is genetically modified to decrease or eliminate the activity of cellulase regulator 1 (CLR1) and to express said recombinant ...  
WO/2017/090684A1
The present invention pertains to: a Thermus aquaticus (Taq) polymerase having a strand substitution activity in which a mold DNA binding site of a Taq DNA polymerase is substituted by amino acid residues that increase the total number o...  
WO/2017/090704A1
[Problem] The purpose of the present invention is to provide cranberry-derived lactobacillales that have high immunomodulatory effects and that can suitably be used in food and drink, and to provide food and drink containing the lactobac...  
WO/2017/090055A1
The present invention relates to a modified yeast strain of Saccharomyces cerevisiae having MCC accession number 0069 with osmo-tolerant, thermo-tolerant, ethanol tolerant and self-flocculation properties. Further, the present invention ...  
WO/2017/090724A1
A DNA methylation editing kit including: (1) a fused protein of inactivated CRISPR-associated endonuclease Cas9 (dCas9) having no nuclease activity and a tag peptide array in which a plurality of tag peptides are linked by linkers, or RN...  
WO/2017/090741A1
A particular region, such as a continuous epithelial structure or the like in a cell aggregation, is automatically detected. A region detecting method according to the present invention includes: an input step (S01) for inputting images ...  
WO/2017/088094A1
Provided is a codon-optimized β- mannase signal peptide(MSP), and a nucleotide sequence thereof is shown as SEQ ID NO:1, and a genetically engineered bacteria comprising the signal peptide and the β- mannase, and a method for manufactu...  
WO/2017/088095A1
The present invention provides a signal peptide and application thereof in synthesis of L-arginine from conjac powder and value enhancement of conjac powder. The signal peptide has a nucleotide sequence of SEQ ID NO: 1. The signal peptid...  
WO/2017/085602A1
The present invention relates to media and fermentation methods for producing polysaccharides in bacterial cell culture. In one aspect, the invention relates to a complex culture medium comprising a vegetable hydrolysate, a yeast extract...  
WO/2017/087563A1
Numerous plant microbes, including the vascular-limited Candidatus spp. —causal agents of citrus greening and potato zebra chip diseases— are non-culturable. The present disclosure relates, according to some embodiments, to compositi...  
WO/2017/085235A1
The present invention relates to recombinant Gram-negative bacterial strains and the use thereof for delivery of repeated domains of a heterologous protein or two or more domains of different heterologous proteins into eukaryotic cells.  
WO/2017/083964A1
The present invention discloses uses of mycotoxin-binding antibodies, including antibodies which bind to mycotoxins in feed and feed ingredients resulting in the reduction or elimination of toxic and carcinogenic effects of mycotoxins. T...  
WO/2017/087672A1
Planting corn in one or more consecutive growing seasons in the same fields causes a yield reduction ("corn-on-corn yield penalty"). We developed methods and inoculants comprising Penicillium bilaii, to reduce corn-on-corn yield penalty....  
WO/2017/087505A1
Provided herein are macromolecular structures comprising charged macromolecules. In particular, provided herein are synthetic neutrophil extracellular traps and uses thereof.  
WO/2017/087330A1
The present invention provides in a process of producing ethanol from starch-containing material comprising: (a) saccharifying the starch-containing material; and (b) fermenting using a fermentation organism; wherein saccharification and...  
WO/2017/085520A1
The invention provides compositions comprising bacterial strains for treating and preventing cancer.  
WO/2017/085241A1
The present invention provides a genetically modified microbial cell for production of lysine, comprising a transgene encoding a polypeptide capable of exporting lysine from the cell. The genetically modified microbial cell for productio...  
WO/2017/087731A1
Methods and compositions for the oxidation of short alkanes by engineered microorganisms expressing recombinant enzymes is described, along with methods of use.  
WO/2017/087682A1
Provided here are methods of using a mutated patatin-like phospholipase IIα ("pPLAIIα," renamed here MATRILINEAL) to induce haploid induction in plants, cloning a pPLAIIα to induce haploid induction in plants, and genetically engineer...  
WO/2017/084635A1
The present invention relates to an oral universal influenza vaccine comprising recombinant lactic acid bacteria which express proteins including but not limited to ferritin protein plus highly-conserved stem fragment of hemagglutinin (H...  
WO/2017/086451A1
Provided are: a culture method with which it is possible to obtain active cells, the culture method being characterized in that lactic acid bacteria are bred by a proprietary culture method for culturing while imparting various stresses ...  
WO/2017/081105A1
The invention provides a novel bacterial strain, identified herein as Bacillus subtilis HF1, which shows utility as an agent for controlling plants diseases and also for promoting the growth of animals. The invention provides agents, met...  
WO/2017/083501A1
This disclosure describes, in one aspect, a cell that includes a biocontainment system. Generally, the biocontainment system includes a coding region whose overexpression decreases growth of the cell, a transcription regulatory region th...  
WO/2017/082611A1
The present invention relates to a strain having the ability to inhibit obesity and a pharmaceutical composition containing the same and, more specifically, to a strain having the ability to inhibit obesity by reducing the concentration ...  
WO/2017/080987A3
The present invention relates to a method for improving biomass production and/or growth rate of a microorganism in a fermentation process, said method comprises the steps of: (i) providing one or more microorganism; (ii) providing a fer...  
WO/2017/081274A1
The present invention relates to processes of producing a fermentation product from readily fermentable sugar-material in a fermentation vat comprising a fermentation medium, comprising: feeding the readily fermentable sugar-material int...  
WO/2017/082181A1
Provided is lactic acid bacteria having an enhanced immunostimulatory action, in a state in which an esterified product of a polyhydric alcohol and a fatty acid is not admixed. Also provided is a method for producing lactic acid bacteria...  
WO/2017/082761A1
The invention relates to agricultural microbiology and particularly to Paenibacillus mucilaginosus strain Pm 2906 (VKPM deposit number B-12259), and to a fertiliser based thereon. A fertiliser for crop cultivation is obtained by the step...  
WO/2017/079936A1
Provided is a system expressing a heterologous gene, containing a Listeria bacteria and a recombinant expression vector. Also provided is a method for expressing a target gene containing the system, a biological agent and a method for pr...  
WO/2017/083351A1
Non-naturally occurring microorganisms are provided that produce taurine and/or taurine precursors, e.g., hypotaurine, sulfoacetaldehyde, or cysteate, utilizing exogenously added enzyme activities. Methods of producing taurine and/or tau...  
WO/2017/080111A1
Provided is a genetically-engineered strain for producing cadaverine. A lysine decarboxylase promoter 1dcCp is replaced as an environmental/nutritional factor-control promoter, and a signal peptide is expressed at the same time; the lysi...  
WO/2017/083858A2
The present disclosure relates to a novel method, expression vectors, and host cells for producing nicotinamide riboside by regulating the pathways that lead to the production of nicotinamide riboside.  
WO/2017/079872A1
Provided are microorganisms genetically modified to overexpress porin polypeptides to enhance the production of lysine and lysine derivatives by the microorganism. Also provided are methods of generating such microorganism, and methods o...  
WO/2017/082294A1
Provided, as substances that exhibit an excellent proliferation promoting effect on stem cells, are bFGF fragment peptides, FGF receptor-binding peptides, peptides comprising a bFGF heparin-binding region, bFGF-binding protein fragment p...  
WO/2017/080987A2
The present invention relates to a method for improving biomass production and/or growth rate of a microorganism in a fermentation process, said method comprises the steps of: (i) providing one or more microorganism; (ii) providing a fer...  
WO/2017/083493A1
This document describes biochemical pathways for biosynthesizing a 3-oxo-7-hydroxyheptanoyl-CoA intermediate using a β-ketothiolase, and enzymatically converting 3-oxo-7-hydroxyheptanoyl-CoA to 7-hydroxyheptanoic acid. - 7-hydroxyheptan...  
WO/2017/079725A1
Modified peptides based on C-terminal PDZ binding domains of PTEN and PHLPP, or PDK1 interacting fragment of PKN2 are described as are methods of using the modified peptides for blocking the activity of PTEN, PHLPP and PKN2 and treating ...  
WO/2017/077104A1
Disclosed are methods for identifying microbes that associate with other microbes, and possess new or improved characteristics. Also disclosed are microbes isolated using the methods. Also disclosed are methods for using the microbes.  
WO/2017/078137A1
The present invention provides: a method for producing an acyl glucuronide of a target compound having a carboxyl group, the method characterized by comprising step A for culturing a microorganism having acyl glucuronide transformation a...  
WO/2017/078029A1
The purpose of the present invention is to provide: a myosatellite cell-culturing material, by means of which cells are proliferated while remaining undifferentiated; and a culturing method using the same. The present invention pertains ...  
WO/2017/079682A1
In some aspects, the invention relates to selectively permeable cell culture vessel storage containers and their methods of use. In some embodiments, the containers comprise a gas-permeable membrane that is selectively impermeable to wat...  
WO/2017/078156A1
The purpose of the present invention is to provide a yeast that produces ethanol from xylose and a method for producing ethanol from xylose with the use of the yeast. The present invention relates to: a transformed yeast prepared by expr...  
WO/2017/077320A1
The present invention relates to genetically modified microorganisms comprising one or more heterologous nucleic acid molecules together encoding at least three different proteins, each protein comprising an enzymatic domain and a bacter...  
WO/2017/077924A1
The present invention addresses the problem of providing a novel FAD-GDH having high practicality. Provided is a glucose dehydrogenase provided with the features below. (1) Effect: the present invention catalyzes a reaction for oxidizing...  
WO/2017/079036A1
This disclosed subject matter concerns nucleic acid molecules and methods of use thereof for control of coleopteran pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in coleopteran p...  
WO/2017/079450A1
Disclosed are methods and compositions for the prevention and treatment of food allergy. In particular, described herein are microbial consortia, including minimal microbial consortia, that can prevent and/or cure food allergy. In certai...  
WO/2017/073533A1
The present invention addresses the problem of providing a means for increasing the efficiency of recovering rare cells in a cell suspension by suppressing adsorption of the cells to the experimental equipment without inhibiting adsorpti...  
WO/2017/071664A1
Provided is a soluble pyrroloquinoline quinone dependent glucose dehydrogenase (PQQ-sGDH) mutant, wherein the amino acid positions thereof correspond to a wild type PQQ-sGDH sequence of Acinetobacter calcoaceticus as shown in SEQ ID NO: ...  
WO/2017/073786A1
Provided are: a glucose dehydrogenase having modified electron transfer properties; and a glucose measurement method and a measurement kit that use said glucose dehydrogenase having modified electron transfer properties. The glucose dehy...  
WO/2017/075485A1
The present invention provides recombinant bacterial cells comprising gene sequence encoding one or more trimethylamine catabolism enzyme(s). The recombinant bacterial cells optionally comprise gene sequence encoding one or more TMA and/...  

Matches 51 - 100 out of 96,203